| scholarly article | Q13442814 |
| P2093 | author name string | McDonald M | |
| McKimm-Breschkin JL | |||
| Blick TJ | |||
| Fenton RJ | |||
| Morley PJ | |||
| Owens IJ | |||
| Sahasrabudhe A | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 95-103 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en | |
| P478 | volume | 246 |
| Q39435565 | A Simple Model of Multivalent Adhesion and Its Application to Influenza Infection. |
| Q33590251 | A coevolution analysis for identifying protein-protein interactions by Fourier transform |
| Q30377012 | A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus |
| Q39685928 | A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. |
| Q37379466 | Animal models for the study of influenza pathogenesis and therapy |
| Q33806746 | Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus |
| Q35173012 | Biophysical measurement of the balance of influenza a hemagglutinin and neuraminidase activities |
| Q57010547 | Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors |
| Q44903223 | Current research on respiratory viral infections: Fifth International Symposium. |
| Q28349496 | Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities |
| Q30377612 | Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir. |
| Q35095879 | Diversity of expressed vlhA adhesin sequences and intermediate hemagglutination phenotypes in Mycoplasma synoviae |
| Q37713714 | Emergence of G186D mutation in the presence of R292K mutation in an immunocompromised child infected with influenza A/H3N2 virus, treated with oseltamivir |
| Q30354224 | Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza. |
| Q24536333 | Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. |
| Q91865564 | Force Spectroscopy Shows Dynamic Binding of Influenza Hemagglutinin and Neuraminidase to Sialic Acid |
| Q34126466 | Functional balance between haemagglutinin and neuraminidase in influenza virus infections |
| Q43733762 | Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture |
| Q28472513 | Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses |
| Q42755170 | Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics |
| Q34083704 | In vitro and in vivo assay systems for study of influenza virus inhibitors |
| Q30416440 | In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir |
| Q30453278 | In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675. |
| Q21562135 | Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance |
| Q33787108 | Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice |
| Q90241717 | Influenza Hemagglutinin and Neuraminidase: Yin⁻Yang Proteins Coevolving to Thwart Immunity |
| Q61807074 | Influenza Virus Neuraminidase Structure and Functions |
| Q34121109 | Influenza hemagglutinin and neuraminidase membrane glycoproteins |
| Q40580607 | Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets |
| Q30305461 | Influenza virus neuraminidase inhibitors |
| Q38014839 | Influenza virus neuraminidase: structure and function. |
| Q45743666 | Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes |
| Q53699476 | Molecular analysis of hemagglutinin, neuraminidase, matrix genes provide insight into the genetic diversity of seasonal H3N2 human influenza a viruses in Bangladesh during July-August, 2012. |
| Q33827578 | Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors |
| Q33819172 | Mutation of neuraminidase cysteine residues yields temperature-sensitive influenza viruses |
| Q34077100 | Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility |
| Q34405859 | Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181 |
| Q34294358 | Position statement: global neuraminidase inhibitor susceptibility network |
| Q98775907 | Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019 |
| Q37169942 | Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase. |
| Q22305941 | Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors |
| Q43258764 | Structural basis for oseltamivir resistance of influenza viruses |
| Q39438794 | The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase |
| Q36949865 | The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir |
| Q34296109 | The importance of specific virus diagnosis and monitoring for antiviral treatment |
| Q39956714 | The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding. |
| Q34452529 | Virus population dynamics, fitness variations and the control of viral disease: an update |
| Q33978456 | Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies |
| Q74167932 | [Antivirals in influenza: mechanism of action and the resistance phenomenon] |
Search more.